Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2013-01-31
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pomegranate juice
pomegranate juice: 500 ml
pomegranate juice
Randomized clinical trial or RCT
placebo
Randomized clinical trial or RCT
placebo
sugar + aroma+ color: 500ml
pomegranate juice
Randomized clinical trial or RCT
placebo
Randomized clinical trial or RCT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pomegranate juice
Randomized clinical trial or RCT
placebo
Randomized clinical trial or RCT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* serum TGs of at least 150 mg/dL,
* waist circumference of more than 102 cm (40 in) in men and more than 88 cm (35 in) in women,
* high-density lipoprotein (HDL) level less than 40 mg/dL in men and less than 50 mg/dL in women,
* blood pressure 135/85 mm Hg or higher, or
* fasting glucose 100 mg/dL or Higher
Exclusion Criteria
* chronic pancreatitis,
* gastrointestinal or connective diseases,
* kidney stones, or
* renal failure,
* alcohol Consumption,
* having an allergy to pomegranate juice,
* a change in diet,
* the large increase in LDL so that required drug treatment.
* use of statins of fibrates, corticosteroids, nitrates, acetyl-salicylic acid or other anti-platelet drugs, oral hypoglycemic drugs, nonsteroidal anti-inflammatory drugs, or drugs interfering with coagulation;
* pregnancy or lactation in the past 6 mo, supplementation with vitamins or antioxidants
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Urmia University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
mohammad alizadeh
Role: STUDY_DIRECTOR
Urmia University of Medical Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urmia University of Medical Sciences
Urmia, , Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1175
Identifier Type: -
Identifier Source: org_study_id